Study of Lemborexant for Irregular Sleep-Wake Rhythm Disorder and Mild to Moderate Alzheimer's Disease Dementia

Facility #1, Willow Grove

Facility #1, Norristown

Facility #1, Raleigh

Facility #2, Durham

Facility #1, Charlotte

Facility #1, Columbia

Facility #1, Atlanta

Facility #1, Macon

Facility #1, Columbus

Facility #1, Orlando

Facility #2, Orlando

Facility #1, Hallandale

Facility #1, Miami Lakes

Facility #1, Miami Springs

Facility #1, Miami

Facility #1, Miami

Facility #1, Sunrise

Facility #1, Brandon

Facility #2, Tampa

Facility #1, Bradenton

Facility #1, Brooksville

Facility #1, Wichita

Facility #1, Little Rock

Facility #1, Rogers

Facility #1, Las Vegas

Facility #1, Santa Monica

Facility #1, Glendale

Facility #1, San Diego

Facility #1, Irvine

Facility #1, Irvine

Facility #1, Costa Mesa

Facility #1, Fullerton

Facility #1, La Jolla

Facility #1, Belmont

Nevada Senior Services (NSS) Adult Day Care Center, Henderson

Facility #1, Toms River

Facility #2, Toms River

Eisai Trial Site #1, Nagoya

Eisai Trial Site #1, Fujisawa

Eisai Trial Site #1, Kawasaki-shi

Eisai Trial Site #1, Wako

Eisai Trial Site #1, Kodaira

Eisai Trial Site #1, Setagaya City

Eisai Trial Site #1, Shinjuku

Eisai Trial Site #1, Tachikawa-shi

Brighton and Sussex Medical School, Brighton

Cognitive Treatment and Research Unit, Crowborough

University of Edinburgh - PPDS, Edinburgh